Compare Stocks
Compare up to four stocks to (SRPT) by adding the symbol or company name.
SRPT
Compare up to three stocks to SRPT by adding the symbol or company name. | Add Stock | Add Stock | Add Stock |
As of May 10, 2024 | SRPT Sarepta Therapeutics, Inc. | -- | -- | -- |
---|---|---|---|---|
Market Value | Market Value 12.35B | Market Value -- | Market Value -- | Market Value -- |
Enterprise Value | EV 12.49B | EV -- | EV -- | EV -- |
Price to Earnings | Price to Earnings 307.67 | Price to Earnings -- | Price to Earnings -- | Price to Earnings -- |
Diluted Earnings Per Share | Diluted EPS TTM 0.43 | Diluted EPS TTM -- | Diluted EPS TTM -- | Diluted EPS TTM -- |
Forward Dividend & Yield | Fwd Div Yld -- | Fwd Div Yld -- | Fwd Div Yld -- | Fwd Div Yld -- |
Sector | Sector Healthcare | Sector -- | Sector -- | Sector -- |
Industry | Industry Biotechnology | Industry -- | Industry -- | Industry -- |
CEO | CEO Mr. Douglas S. Ingram Esq. | CEO -- | CEO -- | CEO -- |
As of May 10, 2024 | SRPT Sarepta Therapeutics, Inc. | -- | -- | -- |
---|---|---|---|---|
1 Week | 1 Week 0.05% | 1 Week -- | 1 Week -- | 1 Week -- |
3 Months | 3 Months 3.01% | 3 Months -- | 3 Months -- | 3 Months -- |
YTD | YTD 35.53% | YTD -- | YTD -- | YTD -- |
1 Year | 1 Year 4.24% | 1 Year -- | 1 Year -- | 1 Year -- |
As of May 10, 2024 | SRPT Sarepta Therapeutics, Inc. | -- | -- | -- |
---|---|---|---|---|
Revenue | Revenue 1.40B | Revenue -- | Revenue -- | Revenue -- |
Operating Expenses | Operating Expenses 1.33B | Operating Expenses -- | Operating Expenses -- | Operating Expenses -- |
Operating Income | Operating Income -94.83M | Operating Income -- | Operating Income -- | Operating Income -- |
Revenue Growth YoY | Rev Gr 1Y 63.10% | Rev Gr 1Y -- | Rev Gr 1Y -- | Rev Gr 1Y -- |
Gross Profit | Gross Profit 1.24B | Gross Profit -- | Gross Profit -- | Gross Profit -- |
As of May 10, 2024 | SRPT Sarepta Therapeutics, Inc. | -- | -- | -- |
---|---|---|---|---|
Inventory | Inventory 373.53M | Inventory -- | Inventory -- | Inventory -- |
Account Receivables Turnover | A/R Turnover 4.66 | A/R Turnover -- | A/R Turnover -- | A/R Turnover -- |
As of May 10, 2024 | SRPT Sarepta Therapeutics, Inc. | -- | -- | -- |
---|---|---|---|---|
Cash Flow from Operations | CF from Ops -533.67M | CF from Ops -- | CF from Ops -- | CF from Ops -- |
Capital Expenditures | CapEx -120.21M | CapEx -- | CapEx -- | CapEx -- |
Cash from Investing Activities | CFI 40.50M | CFI -- | CFI -- | CFI -- |
Free Cash Flow | Free Cash Flow -653.88M | Free Cash Flow -- | Free Cash Flow -- | Free Cash Flow -- |
As of May 10, 2024 | SRPT Sarepta Therapeutics, Inc. | -- | -- | -- |
---|---|---|---|---|
Price to Earnings Per Share | P/E 307.67 | P/E -- | P/E -- | P/E -- |
Forward Price to Earnings Per Share | Fwd P/E 40.32 | Fwd P/E -- | Fwd P/E -- | Fwd P/E -- |
Price to Free Cash Flow Per Share | P/FCF -- | P/FCF -- | P/FCF -- | P/FCF -- |
Price to Book Value Per Share | P/BV 13.01 | P/BV -- | P/BV -- | P/BV -- |
Price to Sales Ratio | P/S 8.97 | P/S -- | P/S -- | P/S -- |
EV/EBITDA | EV/EBITDA 130.49 | EV/EBITDA -- | EV/EBITDA -- | EV/EBITDA -- |
As of May 10, 2024 | SRPT Sarepta Therapeutics, Inc. | -- | -- | -- |
---|---|---|---|---|
Operating Margin | Oper. Margin -6.76% | Oper. Margin -- | Oper. Margin -- | Oper. Margin -- |
Gross Margin | Gross Margin 88.18% | Gross Margin -- | Gross Margin -- | Gross Margin -- |
Profit Margin | Profit Margin 1.20% | Profit Margin -- | Profit Margin -- | Profit Margin -- |
As of May 10, 2024 | SRPT Sarepta Therapeutics, Inc. | -- | -- | -- |
---|---|---|---|---|
Basic Earnings Per Share | EPS 0.44 | EPS -- | EPS -- | EPS -- |
EPS 1Yr Growth | EPS 1Yr Growth -51.32% | EPS 1Yr Growth -- | EPS 1Yr Growth -- | EPS 1Yr Growth -- |
As of May 10, 2024 | SRPT Sarepta Therapeutics, Inc. | -- | -- | -- |
---|---|---|---|---|
Return on Assets | Return on Assets 0.54% | Return on Assets -- | Return on Assets -- | Return on Assets -- |
Return on Capital | Return on Capital -1.04% | Return on Capital -- | Return on Capital -- | Return on Capital -- |
As of May 10, 2024 | SRPT Sarepta Therapeutics, Inc. | -- | -- | -- |
---|---|---|---|---|
Institutional Ownership % | Inst. Own. % 87.31% | Inst. Own. % -- | Inst. Own. % -- | Inst. Own. % -- |